Trumab 150 mg Injection
  1. Home
  2. Pharma Products
  3. Glenmark Pharmaceuticals Ltd
  4. Trumab 150 mg Injection

Trumab 150 mg Injection

Trumab 150 mg Injection contains trastuzumab 150 mg and is a targeted anticancer medicine used for HER2-positive cancers. It is supplied as a vial and administered by intravenous infusion under the supervision of a qualified healthcare professional. Trastuzumab targets the HER2 protein on cancer cells and helps interfere with signals that promote their growth.

BUY NOW

Category

Trumab is a monoclonal antibody used in appropriate treatment regimens for HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction cancers. It binds to the HER2 receptor and interferes with signaling pathways involved in the growth and survival of cancer cells. The dosage and treatment schedule are determined by the treating oncologist according to the cancer type and prescribed regimen. Patients require clinical monitoring during therapy, including assessment of cardiac function, because trastuzumab can cause infusion reactions and may affect heart function.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 150 mg
Dosage Form Injection
Pack Size 1 vial
Route of Administration Intravenous infusion
Manufacturer Glenmark Pharmaceuticals Ltd

Product Also Known As

Trumab 150mg Injection, Trumab 150mg Vial, Trumab 150mg Infusion, Trastuzumab 150mg Injection, Trastuzumab 150mg Infusion, Trastuzumab 150mg Vial